AstraZeneca U.S. president explains trial data, plans for filing for U.S. approval

26

The findings of a large U.S. trial have shown that the coronavirus vaccine developed by AstraZeneca and the University of Oxford is 79% effective in preventing symptomatic illness and 100% effective against severe disease and hospitalization….